STOCK TITAN

Viratech Financials

NBBI
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Viratech (NBBI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score pending refresh

We are recalculating Viratech's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Interest Coverage At Risk
-9.2x

Viratech earns $-9.2 in operating income for every $1 of interest expense (-$241K vs $26K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

Viratech generated $0 in revenue in fiscal year 2025.

EBITDA
N/A
Net Income
N/A
EPS (Diluted)
$-0.01

Viratech earned $-0.01 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$0

Viratech held $0 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
52M

Viratech had 52M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

NBBI Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $0 N/A $0 $0 $0 N/A $0 $0
Cost of Revenue $0 N/A $0 $0 $0 N/A $0 $0
Gross Profit $0 N/A $0 $0 $0 N/A $0 $0
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $10K N/A $52K-51.5% $107K+4296.3% $2K N/A $9K+99.4% $5K
Operating Income -$32K N/A -$85K+32.8% -$127K-670.7% -$16K N/A -$18K-179.0% -$6K
Interest Expense $6K N/A $7K+9.0% $7K+32.8% $5K N/A $5K+25.8% $4K
Income Tax $0 N/A $0 $0 $0 N/A $0 $0
Net Income -$38K N/A -$89K+33.1% -$133K-522.8% -$21K N/A $2.1M+383.5% -$730K
EPS (Diluted) $0.00 N/A $0.00 $0.00 $0.00 N/A $10.34+383.3% $-3.65

NBBI Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $50K0.0% $50K0.0% $50K $0 $0 $0 $0 N/A
Current Assets $0 $0 $0 $0 $0 $0 N/A N/A
Cash & Equivalents $0 $0 $0 $0 $0 $0 $0 $0
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $846K+4.8% $808K+2.6% $787K+2.5% $768K+5.1% $730K+3.0% $709K+3.6% $685K N/A
Current Liabilities $800K+5.0% $762K+2.8% $741K+2.7% $722K+5.5% $684K+3.2% $663K+3.8% $639K N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$796K-5.1% -$758K-2.8% -$737K+4.0% -$768K-5.1% -$730K-3.0% -$709K-3.6% -$685K+75.1% -$2.8M
Retained Earnings -$4.3M-0.9% -$4.2M-0.5% -$4.2M-2.2% -$4.1M-3.3% -$4.0M-0.5% -$4.0M-0.6% -$3.9M N/A

NBBI Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$27K-96.4% -$14K+83.7% -$85K+33.1% -$127K-351.8% -$28K-375.4% -$6K+66.2% -$18K-125.1% -$8K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $27K+96.4% $14K-83.7% $85K-33.1% $127K+351.8% $28K+375.4% $6K-66.2% $18K+125.1% $8K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

NBBI Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -76.8% N/A -178.3% N/A N/A N/A N/A N/A
Current Ratio 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.00 N/A N/A
Debt-to-Equity -1.060.0 -1.070.0 -1.07-0.1 -1.000.0 -1.000.0 -1.000.0 -1.00 N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$758K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Viratech (NBBI) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Viratech (NBBI) reported diluted earnings per share of $-0.01 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Viratech (NBBI) had $50K in total assets as of fiscal year 2025, including both current and long-term assets.

Viratech (NBBI) had 52M shares outstanding as of fiscal year 2025.

Viratech (NBBI) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Viratech (NBBI) had a debt-to-equity ratio of -1.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Viratech (NBBI) has negative shareholder equity of -$758K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Viratech (NBBI) has an interest coverage ratio of -9.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top